Impact of ribavirin dose reductions in hepatitis C virus genotype 1 patients completing peginterferon alfa-2a/ribavirin treatment (Q43034816)

From Wikidata
Jump to navigation Jump to search
scientific article published on 28 December 2006
edit
Language Label Description Also known as
English
Impact of ribavirin dose reductions in hepatitis C virus genotype 1 patients completing peginterferon alfa-2a/ribavirin treatment
scientific article published on 28 December 2006

    Statements

    Impact of ribavirin dose reductions in hepatitis C virus genotype 1 patients completing peginterferon alfa-2a/ribavirin treatment (English)
    Mitchell L Shiffman
    Timothy R Morgan
    Stephanos Hadziyannis
    Fayez M Hamzeh
    Teresa L Wright
    Michael Fried
    28 December 2006
    124-129

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit